Dr. Currier is a cancer early detection focused on identifying and removing screening barriers at a population level. Drawing on her training in health systems and policy (Ph.D.) and public health (M.P.H.), and community engaged research (post-doc), her research explores individual, system, and policy level factors contributing to suboptimal screening rates in populations experiencing cancer disparities compared to the general population. Her prior research investigated community engaged approaches to increase lung cancer screening and barriers to minoritized group participation in cancer early cancer detection research. More recently, her work has shifted to addressing cervical cancer disparities experienced by minority and rural populations. This body of work is investigating human papillomavirus vaccine (HPV) self-collection to identify pre-cancerous lesions and early-stage cancers and the feasibility of integrating HPV-self-collection into rural health care clinic workflows. She is also interested in increasing HPV vaccination uptake through novel health system interventions. 

An early career investigator and co-investigator on several Oregon Health & Science University and National Institutes of Health funded research projects, Dr. Currier has been invited to present at international and national scientific meetings on topics ranging from involving underrepresented populations in cancer early detection research to delivering culturally competent care to heterogeneous populations.

Dr. Currier is a Sylff fellow with the Tokyo Foundation for Policy Research. She has a PhD in Health Systems and Policy from Oregon Health & Sciences University-Portland State University’s School of Public Health in Portland, OR, an MPH in International Health from Oregon State University in Corvallis, OR and a BA from Lewis and Clark College, also located in Portland.